nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Prostaglandins—Bimatoprost—glaucoma	0.169	0.333	CiPCiCtD
Alprostadil—Prostaglandins—Travoprost—glaucoma	0.169	0.333	CiPCiCtD
Alprostadil—Prostaglandins—Latanoprost—glaucoma	0.169	0.333	CiPCiCtD
Alprostadil—PTGER1—Bimatoprost—glaucoma	0.123	0.689	CbGbCtD
Alprostadil—Epoprostenol—Bimatoprost—glaucoma	0.0582	0.252	CrCrCtD
Alprostadil—SLCO2B1—Latanoprost—glaucoma	0.0553	0.311	CbGbCtD
Alprostadil—Dinoprost Tromethamine—Travoprost—glaucoma	0.0482	0.209	CrCrCtD
Alprostadil—Dinoprost Tromethamine—Latanoprost—glaucoma	0.0448	0.194	CrCrCtD
Alprostadil—Dinoprostone—Bimatoprost—glaucoma	0.0399	0.173	CrCrCtD
Alprostadil—Dinoprost Tromethamine—Bimatoprost—glaucoma	0.0399	0.173	CrCrCtD
Alprostadil—Dinoprost Tromethamine—PTGFR—glaucoma	0.000671	0.51	CrCbGaD
Alprostadil—Dinoprostone—PTGFR—glaucoma	0.000516	0.392	CrCbGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000209	0.00681	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000198	0.00646	CbGpPWpGaD
Alprostadil—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000196	0.00641	CbGpPWpGaD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000196	0.00641	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00019	0.0062	CbGpPWpGaD
Alprostadil—PTGIR—Endothelin Pathways—EDN1—glaucoma	0.000182	0.00594	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000174	0.00567	CbGpPWpGaD
Alprostadil—PTGER2—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000162	0.00529	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000157	0.00512	CbGpPWpGaD
Alprostadil—PTGER2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000156	0.0051	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—OPN4—glaucoma	0.000152	0.00495	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000149	0.00486	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000149	0.00486	CbGpPWpGaD
Alprostadil—PTGER2—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000146	0.00476	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000139	0.00454	CbGpPWpGaD
Alprostadil—ABCC5—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000137	0.00446	CbGpPWpGaD
Alprostadil—PTGER1—G alpha (q) signalling events—PTGFR—glaucoma	0.000137	0.00446	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000136	0.00443	CbGpPWpGaD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000134	0.00437	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000132	0.00431	CbGpPWpGaD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—glaucoma	0.000128	0.0976	CrCbGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000128	0.00419	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000128	0.00419	CbGpPWpGaD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000122	0.00399	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000117	0.00383	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000117	0.00383	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—SLC6A13—glaucoma	0.000116	0.00379	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000115	0.00374	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—OPN4—glaucoma	0.000113	0.0037	CbGpPWpGaD
Alprostadil—PTGIR—Endothelin Pathways—NOS3—glaucoma	0.000111	0.00362	CbGpPWpGaD
Alprostadil—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000109	0.00357	CbGpPWpGaD
Alprostadil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000109	0.00357	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000106	0.00346	CbGpPWpGaD
Alprostadil—PTGER1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000106	0.00345	CbGpPWpGaD
Alprostadil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000106	0.00345	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—PTGFR—glaucoma	0.000102	0.00333	CbGpPWpGaD
Alprostadil—SLCO2A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000102	0.00333	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000101	0.00328	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000101	0.00328	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000101	0.00328	CbGpPWpGaD
Alprostadil—SLCO3A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.66e-05	0.00315	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—TXN—glaucoma	9.53e-05	0.00311	CbGpPWpGaD
Alprostadil—ABCC4—Fluoropyrimidine Activity—MTHFR—glaucoma	9.48e-05	0.00309	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.05e-05	0.00295	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.05e-05	0.00295	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—PEX19—glaucoma	8.63e-05	0.00282	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—SLC6A1—glaucoma	8.5e-05	0.00277	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—PEX19—glaucoma	8.25e-05	0.00269	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—SLC6A13—glaucoma	8.05e-05	0.00262	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—TGFB2—glaucoma	7.77e-05	0.00253	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—OPN4—glaucoma	7.66e-05	0.0025	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—OPN4—glaucoma	7.66e-05	0.0025	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	7.66e-05	0.0025	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	7.4e-05	0.00241	CbGpPWpGaD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—NOS3—glaucoma	7.27e-05	0.00237	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.08e-05	0.00231	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—TGFB2—glaucoma	6.93e-05	0.00226	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—PTGFR—glaucoma	6.89e-05	0.00225	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTGFR—glaucoma	6.89e-05	0.00225	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.71e-05	0.00219	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TXN—glaucoma	6.61e-05	0.00216	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—OPN4—glaucoma	6.41e-05	0.00209	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—SLC6A1—glaucoma	5.89e-05	0.00192	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—SOD1—glaucoma	5.89e-05	0.00192	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.83e-05	0.0019	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—OPN4—glaucoma	5.82e-05	0.0019	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PTGFR—glaucoma	5.77e-05	0.00188	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—PEX19—glaucoma	5.72e-05	0.00187	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	5.61e-05	0.00183	CbGpPWpGaD
Alprostadil—SLCO2B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	5.6e-05	0.00183	CbGpPWpGaD
Alprostadil—PTGIR—Platelet homeostasis—NOS3—glaucoma	5.57e-05	0.00182	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.57e-05	0.00182	CbGpPWpGaD
Alprostadil—Headache—Diclofenamide—glaucoma	5.42e-05	0.00107	CcSEcCtD
Alprostadil—Cough—Dorzolamide—glaucoma	5.41e-05	0.00106	CcSEcCtD
Alprostadil—Dry mouth—Brimonidine—glaucoma	5.4e-05	0.00106	CcSEcCtD
Alprostadil—Thrombocytopenia—Acetazolamide—glaucoma	5.4e-05	0.00106	CcSEcCtD
Alprostadil—Rhinitis—Clonidine—glaucoma	5.39e-05	0.00106	CcSEcCtD
Alprostadil—Cough—Travoprost—glaucoma	5.39e-05	0.00106	CcSEcCtD
Alprostadil—Hypertension—Dorzolamide—glaucoma	5.35e-05	0.00105	CcSEcCtD
Alprostadil—Hypoaesthesia—Clonidine—glaucoma	5.35e-05	0.00105	CcSEcCtD
Alprostadil—Rash—Carbachol—glaucoma	5.33e-05	0.00105	CcSEcCtD
Alprostadil—Hypertension—Travoprost—glaucoma	5.33e-05	0.00105	CcSEcCtD
Alprostadil—Dermatitis—Carbachol—glaucoma	5.32e-05	0.00105	CcSEcCtD
Alprostadil—Cough—Brinzolamide—glaucoma	5.32e-05	0.00105	CcSEcCtD
Alprostadil—Oedema—Brimonidine—glaucoma	5.3e-05	0.00104	CcSEcCtD
Alprostadil—Headache—Carbachol—glaucoma	5.29e-05	0.00104	CcSEcCtD
Alprostadil—Pain—Apraclonidine—glaucoma	5.28e-05	0.00104	CcSEcCtD
Alprostadil—Hyperglycaemia—Betaxolol—glaucoma	5.27e-05	0.00104	CcSEcCtD
Alprostadil—Dyspepsia—Bimatoprost—glaucoma	5.27e-05	0.00104	CcSEcCtD
Alprostadil—Infection—Brimonidine—glaucoma	5.26e-05	0.00103	CcSEcCtD
Alprostadil—Hypertension—Brinzolamide—glaucoma	5.26e-05	0.00103	CcSEcCtD
Alprostadil—Cardiac arrest—Timolol—glaucoma	5.25e-05	0.00103	CcSEcCtD
Alprostadil—Syncope—Pilocarpine—glaucoma	5.25e-05	0.00103	CcSEcCtD
Alprostadil—PTGER2—Signaling by GPCR—PTGFR—glaucoma	5.24e-05	0.00171	CbGpPWpGaD
Alprostadil—Nausea—Carteolol—glaucoma	5.23e-05	0.00103	CcSEcCtD
Alprostadil—Headache—Levobunolol—glaucoma	5.21e-05	0.00103	CcSEcCtD
Alprostadil—Discomfort—Dorzolamide—glaucoma	5.21e-05	0.00103	CcSEcCtD
Alprostadil—Shock—Brimonidine—glaucoma	5.21e-05	0.00102	CcSEcCtD
Alprostadil—ABCC5—Fluoropyrimidine Activity—TP53—glaucoma	5.19e-05	0.00169	CbGpPWpGaD
Alprostadil—Discomfort—Travoprost—glaucoma	5.19e-05	0.00102	CcSEcCtD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.18e-05	0.00169	CbGpPWpGaD
Alprostadil—Tachycardia—Brimonidine—glaucoma	5.17e-05	0.00102	CcSEcCtD
Alprostadil—Dry mouth—Dorzolamide—glaucoma	5.16e-05	0.00101	CcSEcCtD
Alprostadil—Loss of consciousness—Pilocarpine—glaucoma	5.15e-05	0.00101	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—SMO—glaucoma	5.15e-05	0.00168	CbGpPWpGaD
Alprostadil—Skin disorder—Brimonidine—glaucoma	5.15e-05	0.00101	CcSEcCtD
Alprostadil—Nausea—Diclofenamide—glaucoma	5.14e-05	0.00101	CcSEcCtD
Alprostadil—Dry mouth—Travoprost—glaucoma	5.14e-05	0.00101	CcSEcCtD
Alprostadil—Acute coronary syndrome—Betaxolol—glaucoma	5.14e-05	0.00101	CcSEcCtD
Alprostadil—Discomfort—Brinzolamide—glaucoma	5.13e-05	0.00101	CcSEcCtD
Alprostadil—Pain—Bimatoprost—glaucoma	5.12e-05	0.00101	CcSEcCtD
Alprostadil—Cough—Pilocarpine—glaucoma	5.11e-05	0.001	CcSEcCtD
Alprostadil—Myocardial infarction—Betaxolol—glaucoma	5.11e-05	0.001	CcSEcCtD
Alprostadil—Dizziness—Latanoprost—glaucoma	5.1e-05	0.001	CcSEcCtD
Alprostadil—ABCC4—Ectoderm Differentiation—PAX6—glaucoma	5.1e-05	0.00166	CbGpPWpGaD
Alprostadil—Feeling abnormal—Apraclonidine—glaucoma	5.08e-05	0.001	CcSEcCtD
Alprostadil—Dry mouth—Brinzolamide—glaucoma	5.07e-05	0.000998	CcSEcCtD
Alprostadil—Oedema—Dorzolamide—glaucoma	5.06e-05	0.000995	CcSEcCtD
Alprostadil—Hypertension—Pilocarpine—glaucoma	5.06e-05	0.000994	CcSEcCtD
Alprostadil—Oedema—Travoprost—glaucoma	5.04e-05	0.00099	CcSEcCtD
Alprostadil—Rash—Methazolamide—glaucoma	5.03e-05	0.000988	CcSEcCtD
Alprostadil—Dermatitis—Methazolamide—glaucoma	5.02e-05	0.000988	CcSEcCtD
Alprostadil—Nausea—Carbachol—glaucoma	5.02e-05	0.000987	CcSEcCtD
Alprostadil—Infection—Travoprost—glaucoma	5e-05	0.000984	CcSEcCtD
Alprostadil—Headache—Methazolamide—glaucoma	4.99e-05	0.000982	CcSEcCtD
Alprostadil—Shock—Dorzolamide—glaucoma	4.98e-05	0.000979	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—LRP12—glaucoma	4.96e-05	0.00162	CbGpPWpGaD
Alprostadil—Hypotension—Brimonidine—glaucoma	4.95e-05	0.000973	CcSEcCtD
Alprostadil—Nausea—Levobunolol—glaucoma	4.94e-05	0.000972	CcSEcCtD
Alprostadil—Infection—Brinzolamide—glaucoma	4.94e-05	0.000971	CcSEcCtD
Alprostadil—Discomfort—Pilocarpine—glaucoma	4.93e-05	0.000969	CcSEcCtD
Alprostadil—Tachycardia—Travoprost—glaucoma	4.92e-05	0.000967	CcSEcCtD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.91e-05	0.0016	CbGpPWpGaD
Alprostadil—Skin disorder—Travoprost—glaucoma	4.89e-05	0.000962	CcSEcCtD
Alprostadil—Hyperhidrosis—Dorzolamide—glaucoma	4.89e-05	0.000962	CcSEcCtD
Alprostadil—Sinusitis—Betaxolol—glaucoma	4.89e-05	0.000961	CcSEcCtD
Alprostadil—Abdominal pain—Apraclonidine—glaucoma	4.88e-05	0.000959	CcSEcCtD
Alprostadil—Rash—Latanoprost—glaucoma	4.87e-05	0.000957	CcSEcCtD
Alprostadil—Dermatitis—Latanoprost—glaucoma	4.86e-05	0.000956	CcSEcCtD
Alprostadil—Dyspepsia—Acetazolamide—glaucoma	4.86e-05	0.000955	CcSEcCtD
Alprostadil—Tachycardia—Brinzolamide—glaucoma	4.85e-05	0.000954	CcSEcCtD
Alprostadil—Headache—Latanoprost—glaucoma	4.84e-05	0.000951	CcSEcCtD
Alprostadil—Skin disorder—Brinzolamide—glaucoma	4.83e-05	0.00095	CcSEcCtD
Alprostadil—ABCC4—NRF2 pathway—TGFB2—glaucoma	4.8e-05	0.00157	CbGpPWpGaD
Alprostadil—Oedema—Pilocarpine—glaucoma	4.78e-05	0.00094	CcSEcCtD
Alprostadil—Bradycardia—Betaxolol—glaucoma	4.76e-05	0.000936	CcSEcCtD
Alprostadil—Infection—Pilocarpine—glaucoma	4.75e-05	0.000934	CcSEcCtD
Alprostadil—Nausea—Methazolamide—glaucoma	4.74e-05	0.000931	CcSEcCtD
Alprostadil—Hypotension—Dorzolamide—glaucoma	4.73e-05	0.000929	CcSEcCtD
Alprostadil—ABCC5—NRF2 pathway—GSTM1—glaucoma	4.71e-05	0.00154	CbGpPWpGaD
Alprostadil—Hypotension—Travoprost—glaucoma	4.71e-05	0.000925	CcSEcCtD
Alprostadil—Shock—Pilocarpine—glaucoma	4.7e-05	0.000925	CcSEcCtD
Alprostadil—Rhinitis—Betaxolol—glaucoma	4.69e-05	0.000922	CcSEcCtD
Alprostadil—Thrombocytopenia—Pilocarpine—glaucoma	4.68e-05	0.00092	CcSEcCtD
Alprostadil—Erythema—Clonidine—glaucoma	4.68e-05	0.00092	CcSEcCtD
Alprostadil—Tachycardia—Pilocarpine—glaucoma	4.67e-05	0.000917	CcSEcCtD
Alprostadil—Dyspepsia—Brimonidine—glaucoma	4.66e-05	0.000917	CcSEcCtD
Alprostadil—Hypoaesthesia—Betaxolol—glaucoma	4.65e-05	0.000915	CcSEcCtD
Alprostadil—Hypotension—Brinzolamide—glaucoma	4.65e-05	0.000914	CcSEcCtD
Alprostadil—Pharyngitis—Betaxolol—glaucoma	4.64e-05	0.000913	CcSEcCtD
Alprostadil—Hyperhidrosis—Pilocarpine—glaucoma	4.62e-05	0.000909	CcSEcCtD
Alprostadil—Feeling abnormal—Acetazolamide—glaucoma	4.55e-05	0.000894	CcSEcCtD
Alprostadil—PTGER1—G alpha (q) signalling events—EDN1—glaucoma	4.54e-05	0.00148	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NARFL—glaucoma	4.54e-05	0.00148	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CA5A—glaucoma	4.54e-05	0.00148	CbGpPWpGaD
Alprostadil—Nervousness—Clonidine—glaucoma	4.54e-05	0.000893	CcSEcCtD
Alprostadil—Pain—Brimonidine—glaucoma	4.53e-05	0.000891	CcSEcCtD
Alprostadil—Visual impairment—Betaxolol—glaucoma	4.51e-05	0.000886	CcSEcCtD
Alprostadil—Muscle spasms—Clonidine—glaucoma	4.5e-05	0.000884	CcSEcCtD
Alprostadil—Hypotension—Pilocarpine—glaucoma	4.47e-05	0.000878	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.46e-05	0.00145	CbGpPWpGaD
Alprostadil—Dyspepsia—Dorzolamide—glaucoma	4.45e-05	0.000876	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Timolol—glaucoma	4.44e-05	0.000872	CcSEcCtD
Alprostadil—Dyspepsia—Travoprost—glaucoma	4.43e-05	0.000872	CcSEcCtD
Alprostadil—Asthenia—Apraclonidine—glaucoma	4.43e-05	0.00087	CcSEcCtD
Alprostadil—Dyspepsia—Brinzolamide—glaucoma	4.38e-05	0.000861	CcSEcCtD
Alprostadil—Pruritus—Apraclonidine—glaucoma	4.37e-05	0.000858	CcSEcCtD
Alprostadil—Body temperature increased—Acetazolamide—glaucoma	4.36e-05	0.000858	CcSEcCtD
Alprostadil—Flushing—Betaxolol—glaucoma	4.34e-05	0.000854	CcSEcCtD
Alprostadil—PTGIR—GPCR downstream signaling—OPN4—glaucoma	4.33e-05	0.00141	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—OPN4—glaucoma	4.33e-05	0.00141	CbGpPWpGaD
Alprostadil—Pain—Dorzolamide—glaucoma	4.33e-05	0.000851	CcSEcCtD
Alprostadil—Pain—Travoprost—glaucoma	4.31e-05	0.000847	CcSEcCtD
Alprostadil—Hyperglycaemia—Timolol—glaucoma	4.31e-05	0.000847	CcSEcCtD
Alprostadil—Asthenia—Bimatoprost—glaucoma	4.29e-05	0.000844	CcSEcCtD
Alprostadil—Pain—Brinzolamide—glaucoma	4.25e-05	0.000836	CcSEcCtD
Alprostadil—Pruritus—Bimatoprost—glaucoma	4.23e-05	0.000832	CcSEcCtD
Alprostadil—Diarrhoea—Apraclonidine—glaucoma	4.22e-05	0.00083	CcSEcCtD
Alprostadil—Dyspepsia—Pilocarpine—glaucoma	4.21e-05	0.000827	CcSEcCtD
Alprostadil—Syncope—Clonidine—glaucoma	4.19e-05	0.000825	CcSEcCtD
Alprostadil—Feeling abnormal—Dorzolamide—glaucoma	4.17e-05	0.00082	CcSEcCtD
Alprostadil—Feeling abnormal—Travoprost—glaucoma	4.15e-05	0.000816	CcSEcCtD
Alprostadil—ABCC5—Disease—LRP12—glaucoma	4.11e-05	0.00134	CbGpPWpGaD
Alprostadil—Loss of consciousness—Clonidine—glaucoma	4.11e-05	0.000808	CcSEcCtD
Alprostadil—Feeling abnormal—Brinzolamide—glaucoma	4.1e-05	0.000806	CcSEcCtD
Alprostadil—ABCC4—Platelet degranulation—FN1—glaucoma	4.1e-05	0.00134	CbGpPWpGaD
Alprostadil—Pain—Pilocarpine—glaucoma	4.09e-05	0.000804	CcSEcCtD
Alprostadil—Cough—Clonidine—glaucoma	4.08e-05	0.000803	CcSEcCtD
Alprostadil—Dizziness—Apraclonidine—glaucoma	4.08e-05	0.000802	CcSEcCtD
Alprostadil—Erythema—Betaxolol—glaucoma	4.07e-05	0.000801	CcSEcCtD
Alprostadil—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.06e-05	0.00133	CbGpPWpGaD
Alprostadil—Abdominal pain—Dorzolamide—glaucoma	4e-05	0.000786	CcSEcCtD
Alprostadil—Body temperature increased—Dorzolamide—glaucoma	4e-05	0.000786	CcSEcCtD
Alprostadil—Sinusitis—Timolol—glaucoma	3.99e-05	0.000785	CcSEcCtD
Alprostadil—Abdominal pain—Travoprost—glaucoma	3.98e-05	0.000783	CcSEcCtD
Alprostadil—Asthenia—Acetazolamide—glaucoma	3.96e-05	0.000779	CcSEcCtD
Alprostadil—Dizziness—Bimatoprost—glaucoma	3.96e-05	0.000778	CcSEcCtD
Alprostadil—Nervousness—Betaxolol—glaucoma	3.96e-05	0.000778	CcSEcCtD
Alprostadil—Feeling abnormal—Pilocarpine—glaucoma	3.94e-05	0.000775	CcSEcCtD
Alprostadil—Discomfort—Clonidine—glaucoma	3.93e-05	0.000774	CcSEcCtD
Alprostadil—PTGIR—Signaling by GPCR—OPN4—glaucoma	3.93e-05	0.00128	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—OPN4—glaucoma	3.93e-05	0.00128	CbGpPWpGaD
Alprostadil—Muscle spasms—Betaxolol—glaucoma	3.92e-05	0.00077	CcSEcCtD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	3.9e-05	0.00127	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PTGFR—glaucoma	3.9e-05	0.00127	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PTGFR—glaucoma	3.9e-05	0.00127	CbGpPWpGaD
Alprostadil—Dry mouth—Clonidine—glaucoma	3.89e-05	0.000766	CcSEcCtD
Alprostadil—PTGER2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	3.89e-05	0.00127	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.89e-05	0.00127	CbGpPWpGaD
Alprostadil—Bradycardia—Timolol—glaucoma	3.89e-05	0.000765	CcSEcCtD
Alprostadil—Dermatitis—Apraclonidine—glaucoma	3.89e-05	0.000764	CcSEcCtD
Alprostadil—Headache—Apraclonidine—glaucoma	3.87e-05	0.00076	CcSEcCtD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.86e-05	0.00126	CbGpPWpGaD
Alprostadil—Rhinitis—Timolol—glaucoma	3.83e-05	0.000753	CcSEcCtD
Alprostadil—Oedema—Clonidine—glaucoma	3.82e-05	0.000751	CcSEcCtD
Alprostadil—Asthenia—Brimonidine—glaucoma	3.8e-05	0.000747	CcSEcCtD
Alprostadil—Infection—Clonidine—glaucoma	3.79e-05	0.000746	CcSEcCtD
Alprostadil—Body temperature increased—Pilocarpine—glaucoma	3.78e-05	0.000743	CcSEcCtD
Alprostadil—Abdominal pain—Pilocarpine—glaucoma	3.78e-05	0.000743	CcSEcCtD
Alprostadil—Diarrhoea—Acetazolamide—glaucoma	3.78e-05	0.000742	CcSEcCtD
Alprostadil—Rash—Bimatoprost—glaucoma	3.77e-05	0.000742	CcSEcCtD
Alprostadil—Dermatitis—Bimatoprost—glaucoma	3.77e-05	0.000741	CcSEcCtD
Alprostadil—Anaemia—Betaxolol—glaucoma	3.76e-05	0.00074	CcSEcCtD
Alprostadil—Shock—Clonidine—glaucoma	3.76e-05	0.000738	CcSEcCtD
Alprostadil—Pruritus—Brimonidine—glaucoma	3.75e-05	0.000737	CcSEcCtD
Alprostadil—Headache—Bimatoprost—glaucoma	3.75e-05	0.000737	CcSEcCtD
Alprostadil—Thrombocytopenia—Clonidine—glaucoma	3.74e-05	0.000735	CcSEcCtD
Alprostadil—Tachycardia—Clonidine—glaucoma	3.73e-05	0.000733	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.72e-05	0.00121	CbGpPWpGaD
Alprostadil—Skin disorder—Clonidine—glaucoma	3.71e-05	0.000729	CcSEcCtD
Alprostadil—Hyperhidrosis—Clonidine—glaucoma	3.69e-05	0.000726	CcSEcCtD
Alprostadil—Visual impairment—Timolol—glaucoma	3.68e-05	0.000724	CcSEcCtD
Alprostadil—Nausea—Apraclonidine—glaucoma	3.66e-05	0.000721	CcSEcCtD
Alprostadil—Syncope—Betaxolol—glaucoma	3.65e-05	0.000718	CcSEcCtD
Alprostadil—Dizziness—Acetazolamide—glaucoma	3.65e-05	0.000718	CcSEcCtD
Alprostadil—Asthenia—Dorzolamide—glaucoma	3.63e-05	0.000714	CcSEcCtD
Alprostadil—Asthenia—Travoprost—glaucoma	3.61e-05	0.000711	CcSEcCtD
Alprostadil—ABCC4—Fluoropyrimidine Activity—TP53—glaucoma	3.6e-05	0.00117	CbGpPWpGaD
Alprostadil—Pruritus—Dorzolamide—glaucoma	3.58e-05	0.000704	CcSEcCtD
Alprostadil—Loss of consciousness—Betaxolol—glaucoma	3.58e-05	0.000704	CcSEcCtD
Alprostadil—Asthenia—Brinzolamide—glaucoma	3.57e-05	0.000702	CcSEcCtD
Alprostadil—Hypotension—Clonidine—glaucoma	3.57e-05	0.000701	CcSEcCtD
Alprostadil—Pruritus—Travoprost—glaucoma	3.56e-05	0.000701	CcSEcCtD
Alprostadil—Cough—Betaxolol—glaucoma	3.55e-05	0.000699	CcSEcCtD
Alprostadil—Nausea—Bimatoprost—glaucoma	3.55e-05	0.000699	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—PTGFR—glaucoma	3.54e-05	0.00115	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTGFR—glaucoma	3.54e-05	0.00115	CbGpPWpGaD
Alprostadil—Pruritus—Brinzolamide—glaucoma	3.52e-05	0.000692	CcSEcCtD
Alprostadil—Dizziness—Brimonidine—glaucoma	3.5e-05	0.000689	CcSEcCtD
Alprostadil—PTGER1—GPCR ligand binding—SMO—glaucoma	3.48e-05	0.00113	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—SMO—glaucoma	3.48e-05	0.00113	CbGpPWpGaD
Alprostadil—Diarrhoea—Dorzolamide—glaucoma	3.46e-05	0.000681	CcSEcCtD
Alprostadil—Headache—Acetazolamide—glaucoma	3.46e-05	0.00068	CcSEcCtD
Alprostadil—Diarrhoea—Travoprost—glaucoma	3.45e-05	0.000678	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB2—glaucoma	3.45e-05	0.00112	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—OPN4—glaucoma	3.44e-05	0.00112	CbGpPWpGaD
Alprostadil—Asthenia—Pilocarpine—glaucoma	3.43e-05	0.000674	CcSEcCtD
Alprostadil—Discomfort—Betaxolol—glaucoma	3.43e-05	0.000673	CcSEcCtD
Alprostadil—Diarrhoea—Brinzolamide—glaucoma	3.4e-05	0.000669	CcSEcCtD
Alprostadil—PTGER2—GPCR ligand binding—EDN1—glaucoma	3.39e-05	0.00111	CbGpPWpGaD
Alprostadil—Dry mouth—Betaxolol—glaucoma	3.39e-05	0.000667	CcSEcCtD
Alprostadil—Pruritus—Pilocarpine—glaucoma	3.38e-05	0.000665	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—LRP12—glaucoma	3.35e-05	0.00109	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LRP12—glaucoma	3.35e-05	0.00109	CbGpPWpGaD
Alprostadil—Dizziness—Dorzolamide—glaucoma	3.35e-05	0.000658	CcSEcCtD
Alprostadil—Rash—Brimonidine—glaucoma	3.34e-05	0.000657	CcSEcCtD
Alprostadil—Dermatitis—Brimonidine—glaucoma	3.34e-05	0.000656	CcSEcCtD
Alprostadil—Dizziness—Travoprost—glaucoma	3.33e-05	0.000655	CcSEcCtD
Alprostadil—Erythema—Timolol—glaucoma	3.33e-05	0.000654	CcSEcCtD
Alprostadil—Oedema—Betaxolol—glaucoma	3.32e-05	0.000653	CcSEcCtD
Alprostadil—Headache—Brimonidine—glaucoma	3.32e-05	0.000652	CcSEcCtD
Alprostadil—Infection—Betaxolol—glaucoma	3.3e-05	0.000649	CcSEcCtD
Alprostadil—Dizziness—Brinzolamide—glaucoma	3.29e-05	0.000647	CcSEcCtD
Alprostadil—Nausea—Acetazolamide—glaucoma	3.28e-05	0.000645	CcSEcCtD
Alprostadil—Diarrhoea—Pilocarpine—glaucoma	3.27e-05	0.000643	CcSEcCtD
Alprostadil—Shock—Betaxolol—glaucoma	3.27e-05	0.000643	CcSEcCtD
Alprostadil—Pain—Clonidine—glaucoma	3.26e-05	0.000642	CcSEcCtD
Alprostadil—ABCC4—NRF2 pathway—GSTM1—glaucoma	3.26e-05	0.00106	CbGpPWpGaD
Alprostadil—Thrombocytopenia—Betaxolol—glaucoma	3.25e-05	0.00064	CcSEcCtD
Alprostadil—Tachycardia—Betaxolol—glaucoma	3.24e-05	0.000638	CcSEcCtD
Alprostadil—Nervousness—Timolol—glaucoma	3.23e-05	0.000635	CcSEcCtD
Alprostadil—Skin disorder—Betaxolol—glaucoma	3.23e-05	0.000635	CcSEcCtD
Alprostadil—Hyperhidrosis—Betaxolol—glaucoma	3.21e-05	0.000632	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—HEYL—glaucoma	3.19e-05	0.00104	CbGpPWpGaD
Alprostadil—Rash—Dorzolamide—glaucoma	3.19e-05	0.000627	CcSEcCtD
Alprostadil—Dermatitis—Dorzolamide—glaucoma	3.19e-05	0.000627	CcSEcCtD
Alprostadil—Rash—Travoprost—glaucoma	3.18e-05	0.000624	CcSEcCtD
Alprostadil—Dermatitis—Travoprost—glaucoma	3.17e-05	0.000624	CcSEcCtD
Alprostadil—Headache—Dorzolamide—glaucoma	3.17e-05	0.000623	CcSEcCtD
Alprostadil—Dizziness—Pilocarpine—glaucoma	3.16e-05	0.000622	CcSEcCtD
Alprostadil—Headache—Travoprost—glaucoma	3.16e-05	0.00062	CcSEcCtD
Alprostadil—Nausea—Brimonidine—glaucoma	3.15e-05	0.000619	CcSEcCtD
Alprostadil—Feeling abnormal—Clonidine—glaucoma	3.15e-05	0.000619	CcSEcCtD
Alprostadil—Rash—Brinzolamide—glaucoma	3.14e-05	0.000617	CcSEcCtD
Alprostadil—Dermatitis—Brinzolamide—glaucoma	3.13e-05	0.000616	CcSEcCtD
Alprostadil—Headache—Brinzolamide—glaucoma	3.12e-05	0.000613	CcSEcCtD
Alprostadil—Hypotension—Betaxolol—glaucoma	3.11e-05	0.000611	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—PTGFR—glaucoma	3.09e-05	0.00101	CbGpPWpGaD
Alprostadil—Abdominal pain—Clonidine—glaucoma	3.02e-05	0.000593	CcSEcCtD
Alprostadil—Body temperature increased—Clonidine—glaucoma	3.02e-05	0.000593	CcSEcCtD
Alprostadil—Rash—Pilocarpine—glaucoma	3.01e-05	0.000593	CcSEcCtD
Alprostadil—Dermatitis—Pilocarpine—glaucoma	3.01e-05	0.000592	CcSEcCtD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.01e-05	0.000982	CbGpPWpGaD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.01e-05	0.000982	CbGpPWpGaD
Alprostadil—Nausea—Dorzolamide—glaucoma	3e-05	0.000591	CcSEcCtD
Alprostadil—Headache—Pilocarpine—glaucoma	2.99e-05	0.000589	CcSEcCtD
Alprostadil—Nausea—Travoprost—glaucoma	2.99e-05	0.000588	CcSEcCtD
Alprostadil—Syncope—Timolol—glaucoma	2.98e-05	0.000587	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—TGFB2—glaucoma	2.98e-05	0.000972	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—C3—glaucoma	2.96e-05	0.000967	CbGpPWpGaD
Alprostadil—Nausea—Brinzolamide—glaucoma	2.95e-05	0.000581	CcSEcCtD
Alprostadil—Dyspepsia—Betaxolol—glaucoma	2.93e-05	0.000575	CcSEcCtD
Alprostadil—Loss of consciousness—Timolol—glaucoma	2.92e-05	0.000575	CcSEcCtD
Alprostadil—Cough—Timolol—glaucoma	2.9e-05	0.000571	CcSEcCtD
Alprostadil—Hypertension—Timolol—glaucoma	2.87e-05	0.000565	CcSEcCtD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.85e-05	0.000929	CbGpPWpGaD
Alprostadil—Pain—Betaxolol—glaucoma	2.84e-05	0.000559	CcSEcCtD
Alprostadil—Nausea—Pilocarpine—glaucoma	2.84e-05	0.000558	CcSEcCtD
Alprostadil—Discomfort—Timolol—glaucoma	2.8e-05	0.00055	CcSEcCtD
Alprostadil—Dry mouth—Timolol—glaucoma	2.77e-05	0.000545	CcSEcCtD
Alprostadil—Asthenia—Clonidine—glaucoma	2.74e-05	0.000539	CcSEcCtD
Alprostadil—Feeling abnormal—Betaxolol—glaucoma	2.74e-05	0.000538	CcSEcCtD
Alprostadil—ABCC5—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.72e-05	0.000888	CbGpPWpGaD
Alprostadil—Oedema—Timolol—glaucoma	2.72e-05	0.000534	CcSEcCtD
Alprostadil—Pruritus—Clonidine—glaucoma	2.7e-05	0.000531	CcSEcCtD
Alprostadil—Infection—Timolol—glaucoma	2.7e-05	0.00053	CcSEcCtD
Alprostadil—Shock—Timolol—glaucoma	2.67e-05	0.000525	CcSEcCtD
Alprostadil—ABCC5—Disease—HEYL—glaucoma	2.65e-05	0.000864	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR1OP—glaucoma	2.65e-05	0.000864	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—SMO—glaucoma	2.64e-05	0.000862	CbGpPWpGaD
Alprostadil—Skin disorder—Timolol—glaucoma	2.64e-05	0.000519	CcSEcCtD
Alprostadil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.63e-05	0.000858	CbGpPWpGaD
Alprostadil—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.63e-05	0.000858	CbGpPWpGaD
Alprostadil—Body temperature increased—Betaxolol—glaucoma	2.63e-05	0.000517	CcSEcCtD
Alprostadil—Hyperhidrosis—Timolol—glaucoma	2.62e-05	0.000516	CcSEcCtD
Alprostadil—Diarrhoea—Clonidine—glaucoma	2.61e-05	0.000514	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—SOD1—glaucoma	2.61e-05	0.000852	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.58e-05	0.000841	CbGpPWpGaD
Alprostadil—Hypotension—Timolol—glaucoma	2.54e-05	0.000499	CcSEcCtD
Alprostadil—Dizziness—Clonidine—glaucoma	2.52e-05	0.000496	CcSEcCtD
Alprostadil—PTGER2—Signaling Pathways—RPTOR—glaucoma	2.42e-05	0.00079	CbGpPWpGaD
Alprostadil—Rash—Clonidine—glaucoma	2.41e-05	0.000473	CcSEcCtD
Alprostadil—Dermatitis—Clonidine—glaucoma	2.4e-05	0.000473	CcSEcCtD
Alprostadil—Headache—Clonidine—glaucoma	2.39e-05	0.00047	CcSEcCtD
Alprostadil—Dyspepsia—Timolol—glaucoma	2.39e-05	0.00047	CcSEcCtD
Alprostadil—Asthenia—Betaxolol—glaucoma	2.38e-05	0.000469	CcSEcCtD
Alprostadil—Pruritus—Betaxolol—glaucoma	2.35e-05	0.000462	CcSEcCtD
Alprostadil—ABCC4—Platelet degranulation—VEGFA—glaucoma	2.35e-05	0.000765	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NCK2—glaucoma	2.34e-05	0.000765	CbGpPWpGaD
Alprostadil—Pain—Timolol—glaucoma	2.32e-05	0.000456	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—OPN4—glaucoma	2.32e-05	0.000757	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—OPN4—glaucoma	2.32e-05	0.000757	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—EDN1—glaucoma	2.29e-05	0.000748	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—EDN1—glaucoma	2.29e-05	0.000748	CbGpPWpGaD
Alprostadil—Diarrhoea—Betaxolol—glaucoma	2.27e-05	0.000447	CcSEcCtD
Alprostadil—Nausea—Clonidine—glaucoma	2.27e-05	0.000446	CcSEcCtD
Alprostadil—PTGIR—Hemostasis—SOD1—glaucoma	2.26e-05	0.000737	CbGpPWpGaD
Alprostadil—Feeling abnormal—Timolol—glaucoma	2.24e-05	0.00044	CcSEcCtD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	2.23e-05	0.000729	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CA1—glaucoma	2.22e-05	0.000724	CbGpPWpGaD
Alprostadil—Dizziness—Betaxolol—glaucoma	2.2e-05	0.000432	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—HEYL—glaucoma	2.16e-05	0.000704	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HEYL—glaucoma	2.16e-05	0.000704	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CTSA—glaucoma	2.15e-05	0.000701	CbGpPWpGaD
Alprostadil—Abdominal pain—Timolol—glaucoma	2.15e-05	0.000422	CcSEcCtD
Alprostadil—Body temperature increased—Timolol—glaucoma	2.15e-05	0.000422	CcSEcCtD
Alprostadil—Rash—Betaxolol—glaucoma	2.1e-05	0.000412	CcSEcCtD
Alprostadil—Dermatitis—Betaxolol—glaucoma	2.09e-05	0.000412	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—PTGFR—glaucoma	2.09e-05	0.000682	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTGFR—glaucoma	2.09e-05	0.000682	CbGpPWpGaD
Alprostadil—Headache—Betaxolol—glaucoma	2.08e-05	0.000409	CcSEcCtD
Alprostadil—ABCC5—Metabolism—CA2—glaucoma	2.03e-05	0.000662	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—C3—glaucoma	2e-05	0.000653	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—C3—glaucoma	2e-05	0.000653	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HDAC9—glaucoma	1.99e-05	0.00065	CbGpPWpGaD
Alprostadil—Nausea—Betaxolol—glaucoma	1.97e-05	0.000388	CcSEcCtD
Alprostadil—Asthenia—Timolol—glaucoma	1.95e-05	0.000383	CcSEcCtD
Alprostadil—Pruritus—Timolol—glaucoma	1.92e-05	0.000378	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—EDN1—glaucoma	1.92e-05	0.000625	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.89e-05	0.000615	CbGpPWpGaD
Alprostadil—Diarrhoea—Timolol—glaucoma	1.86e-05	0.000365	CcSEcCtD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—FN1—glaucoma	1.82e-05	0.000593	CbGpPWpGaD
Alprostadil—Dizziness—Timolol—glaucoma	1.8e-05	0.000353	CcSEcCtD
Alprostadil—PTGER1—Signaling by GPCR—SMO—glaucoma	1.78e-05	0.000582	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—SMO—glaucoma	1.78e-05	0.000582	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB2—glaucoma	1.78e-05	0.000579	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—EDN1—glaucoma	1.74e-05	0.000568	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MMP1—glaucoma	1.72e-05	0.000562	CbGpPWpGaD
Alprostadil—Rash—Timolol—glaucoma	1.71e-05	0.000337	CcSEcCtD
Alprostadil—Dermatitis—Timolol—glaucoma	1.71e-05	0.000336	CcSEcCtD
Alprostadil—Headache—Timolol—glaucoma	1.7e-05	0.000334	CcSEcCtD
Alprostadil—PTGER2—GPCR downstream signaling—C3—glaucoma	1.68e-05	0.000546	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HDAC9—glaucoma	1.65e-05	0.000539	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—CAV1—glaucoma	1.65e-05	0.000539	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RPTOR—glaucoma	1.64e-05	0.000533	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RPTOR—glaucoma	1.64e-05	0.000533	CbGpPWpGaD
Alprostadil—Nausea—Timolol—glaucoma	1.61e-05	0.000317	CcSEcCtD
Alprostadil—PTGIR—Signaling Pathways—NCK2—glaucoma	1.58e-05	0.000517	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NCK2—glaucoma	1.58e-05	0.000517	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—FN1—glaucoma	1.57e-05	0.000513	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SMO—glaucoma	1.56e-05	0.000509	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—C3—glaucoma	1.52e-05	0.000496	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TXN—glaucoma	1.43e-05	0.000466	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NTRK2—glaucoma	1.43e-05	0.000465	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HDAC9—glaucoma	1.35e-05	0.000439	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HDAC9—glaucoma	1.35e-05	0.000439	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SOD1—glaucoma	1.35e-05	0.000439	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—EDN1—glaucoma	1.3e-05	0.000422	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—EDN1—glaucoma	1.3e-05	0.000422	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS3—glaucoma	1.25e-05	0.000407	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGFR—glaucoma	1.22e-05	0.000399	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—EDN1—glaucoma	1.18e-05	0.000384	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—EDN1—glaucoma	1.18e-05	0.000384	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NTRK1—glaucoma	1.16e-05	0.000379	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—C3—glaucoma	1.13e-05	0.000369	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—C3—glaucoma	1.13e-05	0.000369	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTT1—glaucoma	1.11e-05	0.000362	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN2B—glaucoma	1.07e-05	0.00035	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SMO—glaucoma	1.05e-05	0.000344	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SMO—glaucoma	1.05e-05	0.000344	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.04e-05	0.000339	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—EDN1—glaucoma	1.03e-05	0.000336	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—C3—glaucoma	1.03e-05	0.000335	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—C3—glaucoma	1.03e-05	0.000335	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MMP1—glaucoma	1.03e-05	0.000335	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—CAV1—glaucoma	9.84e-06	0.000321	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NTRK2—glaucoma	9.64e-06	0.000314	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NTRK2—glaucoma	9.64e-06	0.000314	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGF—glaucoma	9.45e-06	0.000308	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—FN1—glaucoma	9.37e-06	0.000306	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—glaucoma	9e-06	0.000293	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—C3—glaucoma	8.99e-06	0.000293	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN2B—glaucoma	8.89e-06	0.00029	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCA1—glaucoma	8.84e-06	0.000288	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP1B1—glaucoma	8.84e-06	0.000288	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—glaucoma	8.37e-06	0.000273	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CAV1—glaucoma	8.29e-06	0.00027	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGFR—glaucoma	8.27e-06	0.00027	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGFR—glaucoma	8.27e-06	0.00027	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FN1—glaucoma	7.89e-06	0.000257	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NTRK1—glaucoma	7.86e-06	0.000256	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NTRK1—glaucoma	7.86e-06	0.000256	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—BAD—glaucoma	7.8e-06	0.000254	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—glaucoma	7.45e-06	0.000243	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—glaucoma	7.44e-06	0.000243	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN2B—glaucoma	7.24e-06	0.000236	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN2B—glaucoma	7.24e-06	0.000236	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—glaucoma	7.06e-06	0.00023	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDN1—glaucoma	6.95e-06	0.000227	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDN1—glaucoma	6.95e-06	0.000227	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—glaucoma	6.94e-06	0.000226	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CAV1—glaucoma	6.88e-06	0.000224	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TP53—glaucoma	6.8e-06	0.000222	CbGpPWpGaD
Alprostadil—ABCC5—Disease—BAD—glaucoma	6.47e-06	0.000211	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—glaucoma	6.39e-06	0.000208	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—glaucoma	6.39e-06	0.000208	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—glaucoma	6.27e-06	0.000204	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—glaucoma	6.24e-06	0.000204	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—C3—glaucoma	6.07e-06	0.000198	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—C3—glaucoma	6.07e-06	0.000198	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—glaucoma	5.81e-06	0.00019	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAV1—glaucoma	5.76e-06	0.000188	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—glaucoma	5.65e-06	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—glaucoma	5.65e-06	0.000184	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CAV1—glaucoma	5.6e-06	0.000183	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CAV1—glaucoma	5.6e-06	0.000183	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDKN1B—glaucoma	5.43e-06	0.000177	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—glaucoma	5.36e-06	0.000175	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FN1—glaucoma	5.33e-06	0.000174	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FN1—glaucoma	5.33e-06	0.000174	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BAD—glaucoma	5.27e-06	0.000172	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BAD—glaucoma	5.27e-06	0.000172	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—glaucoma	5.2e-06	0.00017	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—glaucoma	5.03e-06	0.000164	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—glaucoma	4.75e-06	0.000155	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—glaucoma	4.52e-06	0.000147	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDKN1B—glaucoma	4.5e-06	0.000147	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—glaucoma	4.35e-06	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—glaucoma	4.23e-06	0.000138	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—glaucoma	4.23e-06	0.000138	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TP53—glaucoma	4.05e-06	0.000132	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—glaucoma	3.98e-06	0.00013	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDKN1B—glaucoma	3.67e-06	0.00012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDKN1B—glaucoma	3.67e-06	0.00012	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TP53—glaucoma	3.41e-06	0.000111	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—glaucoma	3.4e-06	0.000111	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—glaucoma	3.4e-06	0.000111	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—glaucoma	3.05e-06	9.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—glaucoma	3.05e-06	9.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TP53—glaucoma	2.3e-06	7.52e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TP53—glaucoma	2.3e-06	7.52e-05	CbGpPWpGaD
